Please use this identifier to cite or link to this item:
|Title:||Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.|
|Authors:||Villemagne, Victor L;Doré, Vincent;Burnham, Samantha C;Masters, Colin L;Rowe, Christopher C|
|Affiliation:||Department of Molecular Imaging and Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia|
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
The Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Victoria, Australia
CSIRO, Health and Biosecurity Flagship, The Australian eHealth Research Centre, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
eHealth, CSIRO Health and Biosecurity, Melbourne, Parkville, Victoria, Australia
|Citation:||Nature reviews. Neurology 2018; online first: 7 June|
|Abstract:||In Figure 1 of this article as originally published, the chemical structure at bottom right was incorrectly labelled 18F-PM-PBB3. The text label has been corrected to 18F-PBB3 in the PDF and HTML versions of the article. As of this date, the structure of PM-PBB3 (also known as APN-1607) has not yet been published.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.